Paul Kalb, global leader of Sidley’s Healthcare and FDA group and co-leader of its Global Life Sciences practice, brings an uncommon clinical perspective, grounded in his experience as an attending physician at the Memorial Sloan-Kettering Cancer Center, to bear in his work for a wide range of healthcare clients. He has successfully represented many of the world’s leading drug, biotech and device manufacturers as well as hospitals and other providers in criminal, civil and administrative enforcement actions involving healthcare fraud and abuse and off-label promotion. He has led teams that defended numerous matters and negotiated ground-breaking settlement agreements and Corporate Integrity Agreements. In addition to his work on enforcement matters, Paul counsels private equity firms on life sciences investments and advises both boards of directors and companies on compliance issues. He is also a co-founder of the Medical Information Working Group, a coalition of life sciences companies dedicated to rationalizing the rules governing the exchange of scientific information.
Paul has written numerous articles in legal, medical and industry publications. He speaks regularly at industry conferences. He serves as a member of the Board of Directors of Children's National Hospital.